Sherwin-Williams' Q1 2026 outlook focuses on resilient market conditions and anticipated sales growth driven by strategic initiatives and favorable industry trends.
Generated by Dafinchi AI. Source-grounded AI analysis, not investment advice.
How does Sherwin-Williams expect market resilience and sales growth to evolve in Q1 2026?
Nasdaq’s “record” Q1 2026 growth was supported by multiple, overlapping demand and backlog signals across its platform businesses—most importantly: (1) strong client engagement translating into bookings, (2) expansion/upsell in recurring revenue streams (ARR and ACV), and (3) market-activity and index-volume momentum that feeds near-term revenue and services volumes.
Management explicitly tied Q1 performance to strong client engagement that is “resulting in meaningful growth” across the platform. 1 Within Financial Technology, Nasdaq reported “very strong ACV bookings growth of more than 50%” in Q1, and described it as setting a “new first quarter bookings record.” 2 In addition, Nasdaq reported overall “29% year-over-year increase in Q1 bookings,” driven by AI-ready data adoption and analytics integration work with Databricks. 3
Why it matters for “backlog signals”: bookings are the forward-looking demand metric that best indicates that current growth is not just pulled forward—it is building contracted/committed revenue potential. Nasdaq’s emphasis on “land and expand” and record bookings suggests demand is converting into future recurring revenue. 32
Nasdaq reported overall ARR grew 12% year-over-year to $3.2 billion in Q1. 4 It also highlighted division-level recurring growth in ways consistent with backlog build:
These ARR increases indicate that customers are renewing and expanding, which typically improves the forward revenue run-rate and supports backlog durability. 452
Nasdaq described demand trends that are directly connected to client infrastructure modernization—specifically “cloud-based mission-critical solutions” with AI features in banking and the shift toward “always on markets” and tokenization in Capital Markets. 4 That demand theme was reinforced by management’s discussion of onboarding/implementation momentum, including:
The presence of high AI feature adoption among users signals that value is being realized (which often reduces churn and increases expansion opportunities), supporting ongoing recurring revenue growth and future backlog. 3
Nasdaq’s Market Services/Index performance contributed to the overall growth profile through volume and inflows, which function like a “demand engine” feeding services revenue. Nasdaq reported:
Why it supports “backlog signals”: while volume is not the same as bookings, sustained or rising volumes are a strong near-term indicator that clients are actively using Nasdaq infrastructure—supporting transactions/services activity and the revenue pipeline for those services. 27
On the Capital Access side, Nasdaq pointed to improving issuance activity and strong issuer engagement:
These statements are important because IPO/listings pipeline activity typically supports transaction-driven revenue and can translate into recurring arrangements over time (though Nasdaq’s excerpts here emphasize engagement and pipeline readiness rather than a specific “backlog” number for listings). 46
Nasdaq’s record Q1 performance was characterized by both contracted demand signals (bookings and ARR) and activity signals (market services volumes and index/ETP momentum):
Net result: the excerpts portray a growth engine driven by (a) bookings/ACV/ARR build from AI/cloud-enabled enterprise demand and land-and-expand execution, and (b) elevated market activity (ETPs/derivatives/market-services volumes) reinforcing near-term revenue. 327
Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.
Management frames 2026 Q2 store closures as deliberate pruning to improve profitability and ROA, not a pattern to repeat next year. Franchising is explicitly not part of the long-term strategy, while growth will come from company-owned stores and selective openings.
Sources used
Research questionWhat did management say about Annual store closures vs franchise stance?
Answer outline
Sherwin-Williams' PSG segment expects back-half volume to remain consistent in 2026, with no material sequential deterioration and Q/Q phasing staying stable. The shift from earlier guidance is a higher volume base and pricing adjustments to balance inflation, not a deteriorating volume that must be offset by share gains. The firm continues pursuing share gains, particularly in residential repaint, amid a soft market backdrop.
Sources used
Research questionThank you, operator. Good morning, everybody. Heidi, going back to your, you know, comments on the outlook and, you know, just given the steady increase in interest rates, recently, specific to the PSG segment, Are you embedding any sort of volume deterioration sequentially for the back half of this year, which will be offset by share gain initiatives on your end, you know, to sort of sum to that low single digit volume growth. Is that the right way to think about it? Thank you?
Answer outline
Sherwin-Williams demonstrates strong resilience in Q1 2026, driven by strategic share gains and disciplined pricing amidst ongoing market softness, with positive growth supported by targeted customer and share initiatives.
Sources used
Research questionHow does Sherwin-Williams expect market resilience and sales growth to evolve in Q1 2026?
Answer outline
Sherwin-Williams adopts a disciplined, customer-focused pricing strategy for 2026, emphasizing targeted, surgical price actions with active customer engagement. This approach manages raw-material volatility and ensures sustainable growth.
Sources used
Research questionWhat is Sherwin-Williams' pricing strategy for 2026 and how does it approach customer-specific pricing?
Answer outline
Sherwin-Williams demonstrates resilience in a challenging market environment, focusing on share gains and strategic execution to sustain growth into Q1 2026.
Sources used
Research questionHow does Sherwin-Williams expect market resilience and sales growth to evolve in Q1 2026?
Answer outline
Sherwin-Williams adopts a disciplined, surgical pricing strategy for 2026, focusing on targeted, customer-specific actions facilitated by deep customer relationships. The company emphasizes agility in managing raw-material volatility through combined pricing and cost reduction efforts.
Sources used
Research questionWhat is Sherwin-Williams' pricing strategy for 2026 and how does it approach customer-specific pricing?
Answer outline
On the call, management explained that the AkzoNobel bid was pursued only as a potential fit to strategy at the right price, and that after advancing to a second, premium all-cash offer, they chose to walk away in favor of more attractive uses of shareholder cash. They stressed disciplined capital deployment, no desperation for deals, and a belief in stronger organic growth opportunities.
Sources used
Research questionWhat did management say about AkzoNobel bid rationale and withdrawal?
Answer outline
Nasdaq's Q1 2026 results highlight strong demand signals and backlog indicators across key divisions, supporting continued growth and resilience in a dynamic market environment.
Sources used
Research questionHow does Sherwin-Williams expect market resilience and sales growth to evolve in Q1 2026?
Answer outline
Nasdaq’s exceptional Q1 2026 growth is primarily driven by AI adoption, infrastructure modernizations, and expansion strategies that expand its platform capabilities.
Sources used
Research questionWhat is Sherwin-Williams' pricing strategy for 2026 and how does it approach customer-specific pricing?
Answer outline
This discussion explores Sherwin-Williams' pricing strategy for 2026, focusing on customer-specific approaches and long-term strategic initiatives.
Sources used
Research questionWhat is Sherwin-Williams' pricing strategy for 2026 and how does it approach customer-specific pricing?
Answer outline
Moderna did not set a numeric approval threshold or confirm a 2027 pivotal-data timeline for mRNA-4359 in melanoma. For mRNA-2808, management highlighted safety, response occurrence and durability in heavily pretreated myeloma, but did not provide numeric success criteria or describe a plan to study the therapy earlier in the treatment pathway.
Sources used
Research questionFor mRNA-4359, what efficacy bar would support approval in first- or second-line melanoma, and could it produce pivotal data in 2027? For the T-cell engager in multiple myeloma, what would constitute positive data in a refractory population, and is there a strategy to study it earlier in the treatment pathway?
Answer outline
PGE says its reliability contingency event mechanism expired and is unlikely to return in the near term, as regulators favor broader power-cost reform without a stated timetable. Meanwhile, the company’s O&M reduction program remains active: it generated about $25 million in benefits last year and is expected to continue for roughly two more years, though no future savings target was provided.
Sources used
Research questionWhat are the prospects for continuing the reliability contingency mechanism, why did the commission not continue it, and what is the outlook for the O&M reduction plan?
Answer outline
Dafinchi